doi:10.1111/cas.1299610. Lee JK, Shin JY, Kim S, et al.(EGFR) tyrosine kinase inhibitors (TKIs
期临床试验阶段。这一类药物里,绝大多数都是靶向治疗药物(targeted therapy),有309个,其中细胞增殖信号抑制剂(proliferative signaling inhibitors
Wendling. Meta- - Medscape - Jun 14, 2022.5. SGLT2 Inhibitors Cut AFib Risk in Real-Word Analysis -
选择性5-羟色胺再摄取抑制剂在精神科与非精神科的使用Selective serotonin reuptake inhibitors:选择性5-羟色胺再摄取抑制剂Psychiatric